David Burgstahler Insider Profile
4 Followers
David Burgstahler, Director at AngioDynamics, holds 23.73M shares in RVL Pharmaceuticals (Ticker: RVLPQ), holds 35.39K shares in Wideopenwest (Ticker: WOW), holds 17.79M shares in Lantheus (Ticker: LNTH).
David Burgstahler's Trading History
| RVLPQRVL Pharmaceuticals | Jan 30, 2023 | ― | Uninformative Sell | ― | ― | |
| WOWWideopenwest | Jan 10, 2018 | ― | Uninformative Buy | ― | $184.01K | |
| LNTHLantheus | Sep 11, 2017 | Director | Informative Sell | 1.70M | $1.81B | |
| SYNHSyneos Health | May 24, 2017 | ― | Uninformative Buy | ― | $1.12B | |
| ANGOAngioDynamics | Apr 14, 2017 | Director | Informative Sell | 37.60M | $111.34M | |
| WCRXWarner Chilcott | ― | ― | ― | ― |
You May Also Like
David Burgstahler insider profile FAQ
What is the percentage of profitable transactions made by David Burgstahler?
The percentage of profitable transactions made by David Burgstahler is 53%.
What is the average return per transaction made by David Burgstahler?
The average return per transaction made by David Burgstahler is -5.10%.
What stocks does David Burgstahler hold?
David Burgstahler holds: ANGO, LNTH, WOW, RVLPQ, SYNH, WCRX stocks.
What was David Burgstahler's most profitable transaction?
David Burgstahler’s most profitable transaction was an Informative Buy of SYNH stock on November 6, 2014. The return on the trade was 137.90%.
What is David Burgstahler's role in AngioDynamics?
David Burgstahler's role in AngioDynamics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
